British Biotech plc / Vernalis Group plc
OFT closed case: Anticipated acquisition by British Biotech plc of Vernalis Group plc.
Affected market: Pharmaceutical / biotechnology services
On the basis of the information available to it, the Office of Fair Trading has decided that the proposed acquisition of Vernalis Group plc by British Biotech plc does not qualify for investigation under the mergers provisions of the Enterprise Act 2002, because neither the UK turnover test nor the share of supply test in section 23 of the Act is met. A relevant merger situation has, therefore, not been created.